From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

RFI – Rapid Diagnosis of Infectious Diseases in Austere Environments

by Global Biodefense Staff
May 10, 2013

U.S. Army Medical Research and Materiel Command (USAMRMC) is conducting market research to assess the availability and technical maturity of technologies for rapid diagnosis of infectious diseases in environments with limited infrastructure support.

Prior to determining an acquisition strategy, USAMRMC will use this Request for Information (RFI) to assess the current state of available technologies and gauge industry interest and commercialization outlook for further development of candidates for the US market.

Prioritized diseases of interest impacting military mission readiness include: dengue, leptospirosis, malaria, meningococcal meningitis and noroviral gastroenteritis. Estimated annual purchase quantities are 5,000 assays for each target.

Specifically, the USAMRMC is interested in determining:

Candidate diagnostic products, either in the development pipeline or currently marketed in the US or in foreign markets that can be used to diagnose the priority pathogens
Current technology status of each candidate
FDA clearance status and timelines
Available data on device sensitivity, specificity, external controls, power requirements, weight, footprint, time to result, user complexity and storage
Level of support interested industry sources would require from the DoD in terms of technical and scientific expertise, clinical sites, and research and development funding

USAMRMC also requests industry feedback on strategies by which candidate assays can be combined, kitted, or otherwise optimized to reduce logistical burden and provide cost-savings over time.

Further details are available under Solicitation Number: W81XWH13RFIID. The response deadline is May 21, 2013.

From Our Partners
Tags: DenguePOC DiagnosticsRFIRuggedized

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC